Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment

• diabetes mellitus due to underlying condition (E08.-)
• gestational diabetes (O24.4-)
• neonatal diabetes mellitus (P70.2)
• postpancreatectomy diabetes mellitus (E13.-)
• postprocedural diabetes mellitus (E13.-)
• secondary diabetes mellitus NEC (E13.-)
• type 1 diabetes mellitus (E10.-)
• type 2 diabetes mellitus (E11.-)

poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)

• code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
• code to identify control using:
• injectable non-insulin antidiabetic drugs (Z79.85)
• insulin (Z79.4)
• oral antidiabetic drugs (Z79.84)
• oral hypoglycemic drugs (Z79.84)

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

One of the following 7th characters is to be assigned to codes in subcategory E09.35 to designate laterality of the disease: